Status:
RECRUITING
SBRT for Breast Cancer Oligometastases
Lead Sponsor:
King Hussein Cancer Center
Conditions:
Breast Neoplasm Malignant Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a prospective data collection of treatment outcome for newly diagnosed oligometastatic breast cancers with 1-3 bone metastases. Eligible patients will be identified from the weekly Breast MDC....
Eligibility Criteria
Inclusion
- Women \>18 years old with a pathologically proven breast cancer who present with 1-3 bone metastases will be included.
- Metastases need to be confirmed pathologically if possible, otherwise two different imaging modalities (CTor MRI and bone scan or PET) are needed to confirm metastases.
- Patients should be able to receive the recommended local and systemic treatment and the primary tumor must be controlled at time of SBRT.
- Maximum diameter of individual metastasis metastasis in any dimension ≤ 5 cm; and must be \>5 cm away from each other (defined as Edge to Edge of tumor).
Exclusion
- Non bone metastatic breast cancers
- Prior history of radiotherapy to same sites of SBRT
- Pathologic fractures of involved bones
- Contraindications to radiotherapy including pregnancy and connective tissue disease.
- Patients with impaired cognitive functions.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04424732
Start Date
June 1 2020
End Date
June 1 2026
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Hussein Cancer Center
Amman, Jordan, 11941